Amir Emami1, Fatemeh Javanmardi1, Ali Akbari2, Javad Kojuri3, Hamid Bakhtiari4, Tahereh Rezaei5, Abdolkhalegh Keshavarzi6, Farshad Falahati5. 1. Microbiology Department, Burn & Wound Healing Research Center, Shiraz University of Medical Sciences , Shiraz, Iran. 2. Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences , Shiraz, Iran. 3. Clinical Education Research Center, Shiraz University of Medical Sciences , Shiraz, Iran. 4. Vice Chancellor for Health Affairs Center of Disease Control (CDC), Shiraz University of Medical Sciences , Shiraz, Iran. 5. Vice Chancellor for Treatment, Shiraz University of Medical Sciences , Shiraz, Iran. 6. Surgery Department, General Surgery, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences , Shiraz, Iran.
Abstract
INTRODUCTION: A life-threatening respiratory disease, coronavirus 2019 (COVID-19), has spread across the globe since December 2019. Many prognostic factors have already been put forward to predict the risk of death and other outcomes. The current study is evaluating the survival rate between hypertensive and non-hypertensive infected patients. METHODS: Patients who were included in this study were admitted between 20 February to 1 March 2020 in Fars (southwest of Iran) province hospitals. Data were collected from the electronic base registry which contained demographic information, medical symptoms, and signs, underlying diseases, CT scan results, and final outcome. RESULTS: Of all 1239 positive cases, 159 (12.83%) had known with hypertension ant this group was significantly older than non-hypertensive patients (66.1 years Vs 48.95 years, p < .001). According to Kaplan-Meier survival curve and log-rank test, it was seen hypertensive patients deteriorated more rapidly than non-hypertensive group (p = .032). Moreover, HIV, cardiovascular, and kidney disease were diagnosed as factors that increase the risk of death in hypertensive patients. CONCLUSION: The current study about the survival rate of COVID-19 patients had shown hypertensive patents are in danger of disease severity, although it may be related to their age. Moreover, the probability of other complications like diabetes, smoking, asthma, kidney, and cardiovascular diseases, and either some other infections such as HIV can make the condition complicated and need more consideration to prevent noxious outcomes.
INTRODUCTION: A life-threatening respiratory disease, coronavirus 2019 (COVID-19), has spread across the globe since December 2019. Many prognostic factors have already been put forward to predict the risk of death and other outcomes. The current study is evaluating the survival rate between hypertensive and non-hypertensiveinfectedpatients. METHODS:Patients who were included in this study were admitted between 20 February to 1 March 2020 in Fars (southwest of Iran) province hospitals. Data were collected from the electronic base registry which contained demographic information, medical symptoms, and signs, underlying diseases, CT scan results, and final outcome. RESULTS: Of all 1239 positive cases, 159 (12.83%) had known with hypertension ant this group was significantly older than non-hypertensivepatients (66.1 years Vs 48.95 years, p < .001). According to Kaplan-Meier survival curve and log-rank test, it was seen hypertensivepatients deteriorated more rapidly than non-hypertensive group (p = .032). Moreover, HIV, cardiovascular, and kidney disease were diagnosed as factors that increase the risk of death in hypertensivepatients. CONCLUSION: The current study about the survival rate of COVID-19patients had shown hypertensive patents are in danger of disease severity, although it may be related to their age. Moreover, the probability of other complications like diabetes, smoking, asthma, kidney, and cardiovascular diseases, and either some other infections such as HIV can make the condition complicated and need more consideration to prevent noxious outcomes.
Authors: Eman M Khedr; Enas Daef; Aliae Mohamed-Hussein; Ehab F Mostafa; Mohamed Zein; Sahar M Hassany; Hanan Galal; Shimaa Abbas Hassan; Islam Galal; Amro A Zarzour; Hebatallah M Hassan; Mariam Taher Amin; Maiada K Hashem; Khaled Osama; Ayman Gamea Journal: Egypt J Neurol Psychiatr Neurosurg Date: 2022-08-12
Authors: Mehmood Ahmad; Bilal Mahmood Beg; Arfa Majeed; Sadaf Areej; Sualeha Riffat; Muhammad Adil Rasheed; Sammina Mahmood; Rana Muhammad Zahid Mushtaq; Mian Abdul Hafeez Journal: Front Public Health Date: 2021-04-14